1-4 of 4
Brian Neville
Close
Sort by
Journal Articles

The Oral, Direct Factor Xa Inhibitor BAY 59-7939 Does Not Cross-React with Anti-Heparin/PF4 (Heparin-Induced Thrombocytopenia) Antibodies.

Jeanine M. Walenga, PhD, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Brian Neville, PhD, Walter P. Jeske, PhD, Margaret Prechel, PhD, Harry L. Messmore, PhD, Frank Misselwitz, MD, PhD, Mamdouh Bakhos, PhD
Journal: Blood
Blood (2005) 106 (11): 1883.
https://doi.org/10.1182/blood.V106.11.1883.1883
Published: 2005
Journal Articles

Argatroban, Not Lepirudin or Bivalirudin, Treatment Results in the Generation of Nitric Oxide during Parenteral Administration.

Jeanine M. Walenga, PhD, Daniel Fareed, BS, Chris Schultz, BS, Brian Neville, BS, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Jawed Fareed, PhD
Journal: Blood
Blood (2004) 104 (11): 1849.
https://doi.org/10.1182/blood.V104.11.1849.1849
Published: 2004
Journal Articles

Down Regulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate.

Wolfram Raake, D.V.M., Debra Hoppensteadt, Ph.D., Christopher Schultz, M.S., Brian Neville, Jawed Fareed, Ph.D..
Journal: Blood
Blood (2004) 104 (11): 4073.
https://doi.org/10.1182/blood.V104.11.4073.4073
Published: 2004
Journal Articles

Effect of 1,6-Anhydro Bicyclic Ring Structure on the Pharmacokinetic and Pharmacodynamic Behavior of Low Molecular Weight Heparin.

Walter P. Jeske, Ph.D., Brian Neville, B.S., Qing Ma, Ph.D., Debra A. Hoppensteadt, Ph.D., Jawed Fareed, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1868.
https://doi.org/10.1182/blood.V104.11.1868.1868
Published: 2004